학술논문
Phase 2 Study of Radiation Therapy Plus Low-Dose Temozolomide Followed by Temozolomide and Irinotecan for Glioblastoma: NRG Oncology RTOG Trial 0420
Document Type
Article
Author
Source
In: International Journal of Radiation Oncology Biology Physics . (International Journal of Radiation Oncology Biology Physics, 15 March 2019, 103(4):878-886)
Subject
Language
English
ISSN
1879355X
03603016
03603016